Post-exposure prophylaxis with Immunoglobulins
๐ก Passive Immunity = immediate protection using pre-formed antibodies (immunoglobulins).
Always seek expert guidance (see BNF).
๐งฌ Key Principles
- Protection is given by injecting antibodies from immune donors (plasma/serum).
- Onset = immediate โฑ๏ธ, but short-lived (weeks); can be repeated if required.
- Immunoglobulins = human origin; Antisera = animal origin (rarely used due to serum sickness risk).
- Reactions to human immunoglobulin are rare.
๐ Types of Passive Immunity
- Human normal immunoglobulin (HNIG) โ pooled antibodies from >1000 donors.
- Disease-specific immunoglobulins โ enriched against a single pathogen.
๐ฅ Human Normal Immunoglobulin (HNIG)
- Sterile, concentrated IgG preparation from pooled plasma.
- Contains antibodies to common viruses: hepatitis A, measles, mumps, rubella, varicella, etc.
- Global shortage โ UK Demand Management Programme (see ivig.nhs.uk, Gov.uk guidance).
๐ Clinical Uses of HNIG
- Hepatitis A โ post-exposure prophylaxis (unvaccinated contacts).
- Measles โ exposed child with severe risk factors (e.g. heart/lung disease, immunosuppression).
๐ฏ Human Specific Immunoglobulins
- ๐ฆ Hepatitis B Immunoglobulin (HBIG) โ post-exposure (needle-stick, sexual exposure, neonates of HBsAg+ mothers).
- ๐ Tetanus Immunoglobulin (TIG) โ high-risk wounds if immunisation incomplete/unknown.
- ๐ Rabies Immunoglobulin โ post-exposure prophylaxis (animal bite/scratch in endemic areas).
- ๐ Varicella Zoster Immunoglobulin (VZIG) โ high-risk exposure (immunosuppressed, neonates, pregnant women <20 wks).